Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 951-960 of 1760 for

Edit search filters
  1. A Study Of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy In Patients With Multiple Myeloma Following Autologous Stem Cell Transplant

    Rochester, MN

  2. A Study To Clinically Test The Use Of A Prostate Cancer Knowledge Questionnaire

    Rochester, MN

  3. A Study To Compare Proton Therapy To Photon Radiation Therapy For Esophageal Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, Mankato, MN, Rochester, MN

  4. A Study To Evaluate Pembrolizumab, Ixazomib Citrate, And Dexamethasone To Treat Participants With Relapsed Multiple Myeloma

    Rochester, MN

  5. Gemcitabine Hydrochloride In Treating Patients With Locally Advanced Pancreatic Cancer

    Rochester, MN

  6. Olanzapine For The Treatment Of Chronic Nausea And/or Vomiting In Advanced Cancer Patients

    Mankato, MN, Rochester, MN

  7. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy

    Rochester, MN

  8. A Multi-center Trial To Evaluate Multiple Regimens In Metastatic Pancreatic Cancer

    Rochester, MN

  9. A Study To Evaluate PDS0101 And Pembrolizumab Combination To Treat Subjects With HPV16 + Recurrent And/or Metastatic Head And Neck Squamous Cell Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Testing The Use Of Steroids And Tyrosine Kinase Inhibitors With Blinatumomab Or Chemotherapy For Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia In Adults

    Rochester, MN

.

Mayo Clinic Footer